Suchergebnisse - "Geriatrics/Aging"

  1. 1
  2. 2
  3. 3

    Quelle: Frydendal, T, Christensen, R, Mechlenburg, I, Mikkelsen, L R, Varnum, C, Graversen, A E, Kjærsgaard-Andersen, P, Revald, P H, Hofbauer, C, Bieder, M J, Qassim, H, Munir, M S, Jakobsen, S S, Nielsen, S M, Ingwersen, K G & Overgaard, S 2024, 'Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis', The New England Journal of Medicine, vol. 391, no. 17, pp. 1610-1620. https://doi.org/10.1056/NEJMoa2400141

  4. 4
  5. 5

    Quelle: N Engl J Med

    Schlagwörter: Male, Dissociative Disorders/diagnostic imaging, Sciences sociales & comportementales, psychologie, Emergency Medicine General, Dissociative Disorders/physiopathology, Cognition, Consciousness Disorders/diagnostic imaging, Brain Injuries/complications, Clinical Medicine General, Prospective Studies, Neurosciences & comportement, Cognition/physiology, Psychiatry, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Pulmonary/Critical Care General, Medicine (all), Coma/Brain Death, Rehabilitation, Brain, Geriatrics/Aging, Electroencephalography, Middle Aged, Hospital-Based Clinical Medicine, Magnetic Resonance Imaging, Neurology/Neurosurgery General, Brain Injuries/physiopathology, Pulmonary/Critical Care, Stroke, Emergency Medicine, Consciousness Disorders, Female, Medical Ethics, Adult, Persistent Vegetative State/physiopathology, Psychiatry General, Critical Care, Neurology/Neurosurgery, Dissociative Disorders, Article, Young Adult, Dissociative Disorders/etiology, End-of-Life Care, Humans, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Aged, Brain/physiopathology, Neurosciences & behavior, Consciousness Disorders/physiopathology, Persistent Vegetative State/diagnostic imaging, Head Trauma, Persistent Vegetative State, Brain Injuries/diagnostic imaging, Consciousness Disorders/etiology, Brain/diagnostic imaging, Geriatrics/Aging General, Persistent Vegetative State/etiology, Social & behavioral sciences, psychology, Brain Injuries, Clinical Medicine

    Dateibeschreibung: application/pdf

  6. 6
  7. 7
  8. 8

    Weitere Verfasser: Alberto Papi Michael G. Ison Joanne M. Langley et al.

    Quelle: The New England journal of medicine, Vol. 388, no. 7, p. 595-608 (2023)
    NEW ENGLAND JOURNAL OF MEDICINE

    Dateibeschreibung: application/pdf

  9. 9

    Weitere Verfasser: Devos, David Labreuche, Julien Dušek, Petr et al.

    Quelle: NEW ENGLAND JOURNAL OF MEDICINE
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    New England Journal of Medicine
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    The New England journal of medicine 387(22), 2045-2055 (2022). doi:10.1056/NEJMoa2209254
    The New England Journal of Medicine, 387, 22, pp. 2045-2055
    Devos, D, Labreuche, J, Rascol, O, Corvol, J C, Duhamel, A, Delannoy, P G, Poewe, W, Compta, Y, Pavese, N, Ruzička, E, Dušek, P, Post, B, Bloem, B R, Berg, D, Maetzler, W, Otto, M, Habert, M O, Lehericy, S, Ferreira, J, Dodel, R, Tranchant, C, Eusebio, A, Thobois, S, Marques, A R, Meissner, W G, Ory-Magne, F, Walter, U, De Bie, R M A, Gago, M, Vilas, D, Kulisevsky, J, Januario, C, Coelho, M V S, Behnke, S, Worth, P, Seppi, K, Ouk, T, Potey, C, Leclercq, C, Viard, R, Kuchcinski, G, Lopes, R, Pruvo, J P, Pigny, P, Garçon, G, Simonin, O, Carpentier, J, Rolland, A S, Nyholm, D, Scherfler, C & FAIRPARK-II Study Group 2022, 'Trial of Deferiprone in Parkinson's Disease', New England Journal of Medicine, vol. 387, no. 22, pp. 2045-2055. https://doi.org/10.1056/NEJMoa2209254

    Schlagwörter: administration & dosage [Deferiprone], double blind procedure, dopamine receptor stimulating agent, kidney disease, Dopamine Agents, Levodopa, mediastinum disease, 0302 clinical medicine, therapeutic use [Deferiprone], Deferiprone, nuclear magnetic resonance imaging, parkinsonism, metabolism [Iron], neurodegeneration with brain iron accumulation, adult, Brain, 16. Peace & justice, 3. Good health, [SDV] Life Sciences [q-bio], Parkinson disease, Substantia Nigra, aged, adverse effects [Dopamine Agents], drug withdrawal, Disease Progression, administration & dosage [Dopamine Agents], disease severity, motor dysfunction, administration & dosage [Antiparkinson Agents], metabolism [Parkinson Disease], DOPAMINE TRANSPORTER, agranulocytosis, Article, 03 medical and health sciences, IRON CHELATION, Genetics, diagnostic imaging [Substantia Nigra], metabolism [Substantia Nigra], neutropenia, Humans, human, levodopa, therapeutic use [Antiparkinson Agents], Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience, Hematology/Oncology General, major clinical study, drug therapy [Parkinson Disease], Geriatrics/Aging General, drug efficacy, phase 2 clinical trial, multicenter study, disease exacerbation, randomized controlled trial, Parkinson Disease, Hematology/Oncology, Neuroscience, Geriatrics/​Aging, drug effects [Substantia Nigra], 0301 basic medicine, drug safety, Medizin, hematologic disease, clinical outcome, eye disease, Administration, Oral, heart disease, mental disease, Antiparkinson Agents, therapeutic use [Dopamine Agents], iron, cholinergic receptor blocking agent, deferiprone, iron chelation, adverse effects [Deferiprone], Geriatrics/Aging, neurologic disease, chemistry [Substantia Nigra], female, sub, physiopathology [Parkinson Disease], adverse effects [Iron Chelating Agents], gastrointestinal disease, Neutropenia, analysis [Iron], Iron, Neurology/Neurosurgery, therapeutic use [Levodopa], Iron Chelating Agents, pharmacology [Iron Chelating Agents], respiratory tract disease, male, Double-Blind Method, adverse effects [Antiparkinson Agents], controlled study, ddc:610, diagnostic imaging [Brain], outcome assessment, dopaminergic transmission, perioperative complication, Brain Chemistry, pharmacology [Antiparkinson Agents], skin disease, therapeutic use [Iron Chelating Agents], monoamine oxidase inhibitor, Neurology - Radboud University Medical Center, chemically induced [Neutropenia], pharmacology [Deferiprone], administration & dosage [Iron Chelating Agents], MDS-Unified Parkinson Disease Rating Scale, pharmacology [Dopamine Agents], connective tissue disease, exploratory research, placebo, musculoskeletal disease, neoplasm

    Dateibeschreibung: application/octet-stream

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Weitere Verfasser: Devos, David Labreuche, Julien Rascol, Olivier et al.

    Dateibeschreibung: application/octet-stream

    Relation: info:eu-repo/grantAgreement/633190/EU/Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone/FAIR-PARK-II; New England Journal of Medicine; N Engl J Med; http://hdl.handle.net/20.500.12210/88411

  15. 15
  16. 16
  17. 17
  18. 18

    Quelle: Revista Latino-Americana de Enfermagem; v. 15 (2007): Número Especial; 748-754
    Revista Latino-Americana de Enfermagem; Vol. 15 (2007): Número Especial; 748-754
    Revista Latino-Americana de Enfermagem
    Universidade de São Paulo (USP)
    instacron:USP
    Revista Latino-Americana de Enfermagem, Volume: 15, Issue: spe, Pages: 748-754, Published: OCT 2007

    Dateibeschreibung: application/pdf; text/html

  19. 19
  20. 20